BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Mar 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-28

Reporting Person: Pierce David A (SVP,Pres Urology,Pelvic Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-28	Common Stock	M	4398.0000	$0.0000	Acquired	33107.0000	Direct
2018-02-28	Common Stock	M	2443.0000	$0.0000	Acquired	35550.0000	Direct
2018-02-28	Common Stock	F	3041.0000	$27.2600	Disposed	32509.0000	Direct
2018-02-28	Common Stock	S	4508.0000	$27.5445	Disposed	28001.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-28	Deferred Stock Units	$	M	4398.0000	Disposed	2018-02-28	Common Stock (4398.0000)	Direct
2018-02-28	Deferred Stock Units	$	M	2443.0000	Disposed	2022-02-28	Common Stock (2443.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F3: Represents the weighted average sale price. These shares were sold in multiple transactions at $27.52 and $27.575. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.